Literature DB >> 8212568

The effects of serpin gene mutations on the distinctive pathobiology of cowpox and rabbitpox virus following intranasal inoculation of Balb/c mice.

J P Thompson1, P C Turner, A N Ali, B C Crenshaw, R W Moyer.   

Abstract

Intranasal infection of Balb/c mice with 106 plaque forming units (PFU) of wild-type cowpox virus (CPV) and rabbitpox virus (RPV) induced strikingly different pulmonary pathology despite nearly identical clinical signs of illness and LD50. Intranasal infection with CPV induced severe peribronchial, peribronchiolar, and perivascular hemorrhage with a mixed inflammatory cell infiltrate, bronchial and bronchiolar epithelial cell hyperplasia with intracytoplasmic acidophilic inclusion bodies, and alveolar hemorrhage and edema. In contrast, infection with RPV induced a mixed peribronchial and peribronchiolar inflammatory cell infiltrate, multifocal areas of bronchiolar epithelial cell coagulation necrosis, alveolar edema, and a conspicuous absence of pulmonary hemorrhage. Viremia was not detected following CPV infection and only 1 of 11 mice had brain-associated virus at death. Mice infected with RPV exhibited a viremia 2-3 days after infection and all mice had virus associated with the brain at death. Mice infected with viruses containing certain serine protease inhibitor (SPI) gene mutations (CPV delta SPI-1, CPV delta SPI-3, and RPV SPI-1-) exhibited no difference in clinical disease manifestation when compared with those infected with wild-type viruses. However, inactivation of the SPI-2 genes in either CPV or RPV resulted in disease attenuation and alteration of pulmonary pathology. Mice infected with the CPV delta SPI-2 mutant showed decreased pulmonary hemorrhage, reduced inflammation, and an absence of alveolar edema, while mice infected with the RPV delta SPI-2 mutant had a marked increase in intrapulmonary inflammatory cells and only a transient viremia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8212568     DOI: 10.1006/viro.1993.1594

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Complete sequence and genomic analysis of murine gammaherpesvirus 68.

Authors:  H W Virgin; P Latreille; P Wamsley; K Hallsworth; K E Weck; A J Dal Canto; S H Speck
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.

Authors:  Meike S Gratz; Yasemin Suezer; Melanie Kremer; Asisa Volz; Monir Majzoub; Kay-Martin Hanschmann; Ulrich Kalinke; Astrid Schwantes; Gerd Sutter
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.

Authors:  Timothy R Wagenaar; Bernard Moss
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

4.  Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses.

Authors:  J Macen; A Takahashi; K B Moon; R Nathaniel; P C Turner; R W Moyer
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 5.  The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.

Authors:  Brian C DeHaven; Kushol Gupta; Stuart N Isaacs
Journal:  J Gen Virol       Date:  2011-06-29       Impact factor: 3.891

6.  The inflammasome as a target of modulation by DNA viruses.

Authors:  Lisi Amsler; Daniel Malouli; Victor DeFilippis
Journal:  Future Virol       Date:  2013-04-01       Impact factor: 1.831

7.  Serp2, an inhibitor of the interleukin-1beta-converting enzyme, is critical in the pathobiology of myxoma virus.

Authors:  F Messud-Petit; J Gelfi; M Delverdier; M F Amardeilh; R Py; G Sutter; S Bertagnoli
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells.

Authors:  P C Turner; M C Sancho; S R Thoennes; A Caputo; R C Bleackley; R W Moyer
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Resistance of interleukin-1beta-deficient mice to fatal Sindbis virus encephalitis.

Authors:  X H Liang; J E Goldman; H H Jiang; B Levine
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.

Authors:  Qian Zhang; Chunguang Liang; Yong A Yu; Nanhai Chen; Thomas Dandekar; Aladar A Szalay
Journal:  Mol Genet Genomics       Date:  2009-08-22       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.